編號
R3-006
徵稿主題
Clinical Trial / Chemotherapy / Targeted Therapy / Immunotherapy / Cell Therapy
題目
評估在 HER2 陽性非病理完全緩解乳癌病患，T-DM1 治療後加用Neratinib的療效
作者群
洪志強1,
林敬翰2,
曾彥敦3,
高理鈞4,
林金瑤5,
謝宗諺6,
劉良智7
服務單位
1 Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan
2 Breast Surgical Oncology Department, Changhua Christian Hospital, Changhua 500209, Taiwan
3 Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
4 Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
5 Breast Medical Center, Division of General Surgery, Department of Surgery, Taichung Tzu Chi Hospital, Taichung, Taiwan
6 Division of Breast Surgery, Department of Surgery, Taipei Veterans General Hospital, Taiwan.
7 Department of Surgery, China Medical University Hospital, Taichung, Taiwan
